Be sure to catch up on our latest webinar hosted by Dr. Michael Sy to explore the MSDA Test in a clinical setting. Watch now.

Unlocking the Unknown in Multiple Sclerosis Care

A simple and accessible blood test provides clinical, data-driven clues

The Octave® MSDA Test

The MSDA Test is the first and only multi-analyte biomarker blood test developed specifically to measure MS disease activity.

Detailed, personalized reporting empowers patients and providers to make care decisions with confidence.

Clinical decisions based on objective biomarkers

Providers

Informing Decision Points
Incorporating the Octave MSDA test adds new insights to consider when making treatment choices.

Patients

Confidence with Consistency
Multiple sclerosis is clouded with uncertainty. Your Octave MSDA test results provide data-driven measurements to define your disease activity level.

At the forefront of precision medicine

Personalized insights for neurodegenerative diseases can transform care across a range of clinical scenarios.

MS DIsease Activity

MS Disease Progression

Parkinson's Disease

Alzheimer's Disease